MicroRNAs (miRNAs) that target ZBTB20 and the long non-coding RNA (IncRNA) ZBTB20-AS4 are also implicated in the classification and prognosis of patients with low-grade gliomas [97,98,99]. This evidence concerns the gene ZBTB20 and central nervous system cancer.